Clinical Trials Directory

Trials / Completed

CompletedNCT02482662

Diagnosis Test for Gestational Diabetes Mellitus

Assessment of the Diagnosis Test for Gestational Diabetes Mellitus

Status
Completed
Phase
Study type
Observational
Enrollment
104 (actual)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Gestational diabetes mellitus (GDM) is an asymptomatic disease. Diagnosis is based on a oral glucose tolerance test (OGTT) requiring pregnant women to absorb 75g of glucose while fasting since midnight and to stay sober for another two hours. These OGTTs are poorly tolerated by pregnant women. As many OGTT are false positive according to self-monitoring blood glucose (SMBG), the investigators need now to determine the percentage of OGTT results that are false negative. The comparison of the two tests (OGTT and SMBG) in the same patient with normal results of OGTT will determine the exact percentage of false negative OGTT results. The opinion of women will also be taken into account. In the everyday clinic, many report that they prefer SMBG to OGTT because they do not have to be fasting, to drink non palatable drink and to attend a 2-hour visit in their schedule. However, no opinion study has yet been performed, the investigators will investigate formally what women think using a questionnaire.

Conditions

Interventions

TypeNameDescription
PROCEDUREDiagnosisOral glucose tolerance test and self-monitoring blood glucose

Timeline

Start date
2014-11-01
Primary completion
2015-12-01
Completion
2017-10-01
First posted
2015-06-26
Last updated
2018-05-03

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02482662. Inclusion in this directory is not an endorsement.